Patient Experience and Bowel Preparation for Transvaginal Surgical Management of Vaginal Prolapse
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01431040|
Recruitment Status : Completed
First Posted : September 9, 2011
Last Update Posted : June 16, 2014
Preoperative bowel preparation for surgical management of pelvic floor disorders is performed inconsistently, and includes no prep, the use of dietary changes or bowel altering interventions. Retrospective studies of emergency colonic surgery first demonstrated a low rate of infectious complications without a bowel prep. Recently, data supporting the routine use of mechanical cleansing for elective colorectal surgery has demonstrated the surgical outcomes are similar between patients that undergo a bowel preparation versus those that do not, indicating that the long held dogma of mechanical bowel preparation should be used selectively. Despite routine use, there is a paucity of literature addressing the approach to, and/or need for preoperative bowel management at the time of vaginal reconstructive or obliterative surgery. The majority of the pelvic floor disorder population is older, tending to have more bowel dysfunction (especially symptoms of constipation) than younger women.
The aim of this study is to evaluate preoperative bowel management strategy as it relates to the total care of the vaginal surgery patients' intra-and post-operative bowel function and overall patient experience. Two commonly used pre-operative bowel prep strategies: no preoperative bowel prep versus clear fluids and 2-enema prep. The aim is to assess the value of bowel preparation or diet change in vaginal surgery, both from the physician's and patient's point of view. In this pilot study, subjects are randomized to either a clear liquid diet the day prior to surgery with 2 enemas and nothing by mouth (NPO) after midnight, or NPO after midnight without any dietary changes or enemas.
Our aims are:
*Primary - To assess the surgeons' objective intraoperative evaluation of the effects of bowel preparation (adequate visualization, stooling during case, difficulty with bowel handling) *Secondary - (1)To characterize the patients' experience and acceptance of preoperative bowel management regimen versus no preoperative bowel preparation(2) To characterize the patients' postoperative experience and determine if the preoperative bowel regimen affects time to first bowel movement/first normal stool as well as stool experience as recorded by bowel diary (3)Evaluate the incidence of complications between the two groups (4)Characterize other descriptive qualities of the patients' operative experience(duration of case, length of hospital stay)
|Condition or disease||Intervention/treatment||Phase|
|Value of the Bowel Preparation and Diet Change Versus no Intervention Preoperative Bowel Regimen||Other: No bowel prep Other: Clear liquid diet and 2 Fleet's enemas||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||150 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Patient Experience and Bowel Preparation for Transvaginal Surgical Management of Vaginal Prolapse|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||August 2012|
|Actual Study Completion Date :||August 2013|
Active Comparator: Group A
Group A will have no bowel preparation and be permitted a regular diet the day prior to surgery until midnight.
Other: No bowel prep
Participants in this group will have a regular diet and no bowel prep the day prior surgery up until midnight.
Active Comparator: Group B
Participants in this group will consume a clear liquid diet and perform 2 Fleets enemas in the late afternoon the day before surgery and nothing after midnight.
Other: Clear liquid diet and 2 Fleet's enemas
Participants in this group will receive a clear liquid diet and 2 Fleets enemas in the late afternoon prior to surgery.
Other Name: Fleets Saline Enema
- Surgeon assessment of bowel preparation [ Time Frame: Will be evaluated at 1 year ]The primary outcome measure will be measured using the surgeon satisfaction questionnaire which is filled out immediately post-op. The surgeon assessment of the bowel preparation and its potential outcome on the surgical field (adequate visualization, stooling during case, and difficulty with bowel handling) will be measured.
- Participant experience and acceptance of preoperative bowel management verses no preoperative bowel preparation [ Time Frame: Will be evaluated at 1 year ]Participants will complete a patient assessment/satisfaction questionnaire.
- Bowel Diary and Bristol Stool Scale [ Time Frame: Will be evaluated at 1 year ]Participants will receive 3 seven day bowel diaries,completing one week prior to surgery, and 2 weeks post-operatively. The Bristol Stool Scale is also included as part of the diary and participants are to record each bowel movement during the 3 week period. The information is returned to the physician at the post-operative visit, which occurs approximately 6 weeks after surgery.
- Complications between the two groups [ Time Frame: Will be evaluated at 1 year ]Any complications that arise will be assessed as they occur and the incidence of complications, if any between the two groups, including wound infection (as defined by erythema, purulent material that was treated with antibiotics, re-operation, or drainage), surgical site breakdown, bowel injury or other unintended injury of adjacent anatomy will be assessed after all the procedures are completed.
- Duration of the Case [ Time Frame: Will be evaluated at 1 year ]This relates to the overall operative procedure recorded in total operative time.
- Length of hospital stay [ Time Frame: Will be evaluated at 1 year ]The length of stays will be assessed to gather the average time of stay.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01431040
|United States, Alabama|
|University of Alabama at Birmingham, The Kirklin Clinic|
|Birmingham, Alabama, United States, 35233|
|Principal Investigator:||Alicia C Ballard, MD||University of Alabama at Birmingham|